Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Broad based buying in markets
Fri, 21 Feb 11:30 am

After opening firm, the Indian indices are trading well above the dotted line in the morning session. All sectoral indices are trading in the green. The buying interest is the highest in banking and FMCG stocks.

The BSE-Sensex is trading up 175 points and the NSE-Nifty is trading up 55 points. The BSE Mid Cap index is trading up 0.6% and the BSE Small Cap index is trading up 0.7%. The rupee is trading at 62.15 to the US dollar.

Telecom stocks are trading mixed today. While Tata Teleservices and Mahanagar Telephone Nigam Limited (MTNL) are leading the gainers, Bharti Airtel and Reliance Communications are leading the losers. India's largest telecom service provider, Bharti Airtel, is facing legal troubles in Africa. Its subsidiary in the country of Nigeria has lost a long standing case to Econet Wireless Nigeria (EWN). The case relates to the shareholding of the company. A Nigerian court has upheld EWN's claim that it holds 5% stake in the firm and Airtel has been ordered to pay it a compensation of about US$ 3 bn. Bharti has challenged the order in the Supreme Court of Nigeria. Bharti Airtel holds 79.06% stake in Airtel Nigeria. Nigeria is the largest market for Airtel in Africa as it contributes about 30% of revenues from the continent. Bharti Airtel is trading down 0.8% today.

Indian pharma stocks are trading mixed today. While Panacea Biotech and Ranbaxy are trading lower, Natco Pharma and Dishman Pharma are trading higher. Sun Pharma has announced its 3QFY14 results. The company has reported 51% YoY growth in sales led by growth in domestic and international formulation business. Its US generics business did well which grew by 79% YoY during the quarter. The company continued to benefit from drugs such as Doxil where it is the sole supplier in the US in light of the problems that the innovator Johnson & Johnson is facing. Its operating margins improved by 1.9% to 46.4% for the quarter largely on account of reduction in raw material and staff costs (as percentage of sales). Strong growth in operating profits and higher other income along with miniscule growth in tax expenses, led to healthy growth in bottomline by 74% YoY.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Broad based buying in markets". Click here!

  

Related Views on News

BHARTI AIRTEL 2019-20 Annual Report Analysis (Annual Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

Here's an analysis of the annual report of BHARTI AIRTEL for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of BHARTI AIRTEL. Also includes updates on the valuation of BHARTI AIRTEL.

BHARTI AIRTEL 2018-19 Annual Report Analysis (Annual Result Update)

Sep 9, 2019 | Updated on Sep 9, 2019

Here's an analysis of the annual report of BHARTI AIRTEL for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of BHARTI AIRTEL. Also includes updates on the valuation of BHARTI AIRTEL.

BHARTI AIRTEL Announces Quarterly Results (1QFY20); Net Profit Down 890.7% (Quarterly Result Update)

Aug 2, 2019 | Updated on Aug 2, 2019

For the quarter ended June 2019, BHARTI AIRTEL has posted a net profit of Rs 25 bn (down 890.7% YoY). Sales on the other hand came in at Rs 207 bn (up 3.3% YoY). Read on for a complete analysis of BHARTI AIRTEL's quarterly results.

BHARTI AIRTEL Announces Quarterly Results (4QFY19); Net Profit Up 144.7% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, BHARTI AIRTEL has posted a net profit of Rs 6 bn (up 144.7% YoY). Sales on the other hand came in at Rs 206 bn (up 4.9% YoY). Read on for a complete analysis of BHARTI AIRTEL's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living (Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021 (Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla (Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE TECK


Feb 26, 2021 (Close)

S&P BSE TECK 5-YR ANALYSIS

COMPARE COMPANY

MARKET STATS